A multi-scale model of dendritic cell education and trafficking in the lung: Implications for T cell polarization

Annals of Biomedical Engineering

Volumn 35, Issue 6, 2007, Pages 937-955

  Klinke II, David J ^a,b  

^a West Virginia University   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Antigen presentation; Cellular heterogeneity; Immunosurveillance; Ordinary differential equations; Translational research

Indexed keywords

ANTIGENS; COMPUTATIONAL METHODS; IMMUNIZATION; MATHEMATICAL MODELS; ORDINARY DIFFERENTIAL EQUATIONS; PHYSIOLOGICAL MODELS; RESPIRATORY SYSTEM;

ANTIGEN PRESENTATION; CELLULAR HETEROGENEITY; IMMUNOSURVEILLANCE; TRANSLATIONAL RESEARCH;

CELLS;

CYTOKINE; IMMUNOLOGIC FACTOR;

ADAPTATION; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL MOTION; CELL POLARITY; COMPUTER SIMULATION; CYTOLOGY; DENDRITIC CELL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LUNG; T LYMPHOCYTE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL MOVEMENT; CELL POLARITY; COMPUTER SIMULATION; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNITY, NATURAL; IMMUNOLOGIC FACTORS; LUNG; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 34249740104     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-007-9318-6     Document Type: Conference Paper

References (59)

1. Abbas, A. K., and C. A. Janeway Jr. Immunology: Improving on nature in the twenty-first century. Cell 100:129-138, 2000.
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811, 2000.
3. Batra, V., A. I. Musani, A. T. Hastie, S. Khurana, K. A. Carpenter, J. G. Zangrilli, and S. P. Peters. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-ß1, TGF-ß2, Interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on α-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin. Exp. Allergy 34:437-444, 2004.
4. Catron, D. M., A. A. Itano, K. A. Pape, D. L. Mueller, and M. K. Jenkins. Visualizing the first 50 hr of the primary immune response to a soluble antigen. Immunity 21:341-347, 2004.
5. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, I. Durand, M. Cella, A. Lanzavecchia, and J. Banchereau. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis, Blood 90:1458-1470, 1997.
6. Desai, B. B., P. M. Quinn, A. G. Wolitzky, P. K. Mongini, R. Chizzonite, and M. K. Gately. IL-12 receptor. II. Distribution and regulation of receptor expression. J. Immunol. 148:3125-3132, 1992.
7. Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D. W. Buck, and J. Schmitz. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct, subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-6046, 2000.
8. Ebner, S., G. Ratzinger, B. Krosbacher, M. Schmulh, A. Weiss, D. Reider, R. A. Kroczek, M. Herold, C. Heufler, P. Fritsch, and N. Romani. Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus Is given at the onset of maturation, and Is further enhanced by IL-4. J. Immunol. 166:633-641, 2001.
9. Elgeti, K. A new equation for correlating a pipe flow reactor with a cascade of mixed reactors. Chem. Eng. Sci. 51:5077-5080, 1996.
10. FDA. Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. U.S. Department of Health and Human Services, Food and Drug Administration, 2004. URL http://www.fda.gov/oc/initiatives/ criticalpath/whitepaper.pdf.
11. Fecek, R. J., R. Busch, H. Lin, K. Pal, C. A. Cunningham, and C. F. Cuff. Production of Alexa Fluor 488-labeled reovirus and characterization of target cell binding, competence, and immunogenicity of labeled virions. J. Immunol. Methods 314:30-37, 2006.
12. Fujii, S., K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607-1618, 2004.
13. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. The Interleukin-12/ Interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495-521, 1998.
14. Germain, R. N. The art of the probable: system control in the adaptive immune system. Science 293:240-245, 2001.
15. Heinzel, F. P., A. M. Hujer, F. N. Ahmed, and R. M. Rerko. In vivo production and function of IL-12 p40 homodimers. J. Immunol. 158:4381-4388, 1997.
16. Herpen, C. M. V., R. Huijbens, M. Looman, J. de Vries, H. Marres, D. Van, R. Hermsen, G. J. Adema, and P. D. Mulder. Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human Interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells. Clin. Cancer Res. 9:2950-2956, 2003.
17. Hochrein, H., M. O'Keeffe, T. Luft, S. Vandenabeele, R. J. Grumont, E. Maraskovsky, and K. Shortman. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:823-833, 2000.
18. Huh, J. C., D. H. Strickland, F. L. Jahnsen, D. J. Turner, J. A. Thomas, S. Napoli, I. Tobagus, P. A. Stumbles, P. D. Sly, and P. G. Holt. Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J. Exp. Med. 198:19-30, 2003.
19. Ingulli, E., A. Mondino, A. Khoruts, and M. K. Jenkins. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J. Exp. Med. 185:2133-2141, 1997.
20. Irish, J. M., R. Hovland, P. O. Krutzik, O. D. Perez, O. Bruserud, B. T. Gjertsen, and G. P. Nolan. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118:217-228, 2004.
21. Jacobson, N. G., S. J. Szabo, R. M. Weber-Nordt, Z. Zhong, R. D. Schreiber, J. E. Darnell, and K. M. Murphy. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181:1755-1762, 1995.
22. Jahnsen, F. L., E. D. Moloney, T. Hogan, J. W. Upham, C. M. Burke, and P. G. Holt. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 56:823-826, 2001.
23. Janeway, C. A., P. Travers, M. Walport, and M. Shlomchik. Immunobiology: The Immune System in Health and Disease. New York: Garland Publishing, 2001, 732 pp.
24. Jenkins, M. K., A. Khoruts, E. Ingulli, D. L. Mueller, S. J. McSorley, R. L. Reinhardt, A. Itano, and K. A. Pape. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19:23-45, 2001.
25. Kalinski, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20:561-567, 1999.
26. Kalinski, P., J. H. Schuitemaker, C. M. Hilkens, and M. L. Kapsenberg. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a + CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161:2804-2809, 1998.
27. Kalinski, P., P. L. Vieira, J. H. Schuitemaker, E. C. de Jong, and M. L. Kapsenberg. Prostaglandin E(2) is a selective inducer of Interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 97:3466-3469, 2001.
28. Khoo, M. C. K. Physiological Control Systems: Analysis, Simulation, and Estimation. Piscataway, NJ: IEEE Press Series on Biomedical Engineering, 2000.
29. Klinke, D. J. An age-structured model of dendritic cell trafficking in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 291:L1038-L1049, 2006.
30. Klinke, D. J. The ratio of P40 monomer to dimer is an important determinant of IL-12 bioactivity. J. Theor. Biol. 240:323-335, 2006.
31. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. Kinetics of dendritic cell activation: impact on priming of Th1, Th2 and nonpolarized T cells. Nat. Immunol. 1:311-316, 2000.
32. Ling, P., M. K. Gately, U. Gubler, A. S. Stern, P. Lin, K. Hollfelder, C. Su, Y. C. Pan, and J. Hakimi. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:116-127, 1995.
33. Lorenzon, P., E. Vecile, E. Nardon, E. Ferrero, J. M. Harlan, F. Tedesco, and A. Dobrina. Endothelial cell E-and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. J. Cell Biol. 142:1381-1391, 1998.
34. Luft, T., M. Jefford, P. Luetjens, T. Toy, H. Hochrein, K.-A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets. Blood 100:1362-1372, 2002.
35. Matzinger, P. The danger model: a renewed sense of self. Science 296:301-305, 2002.
36. Medzhitov, R., and C. A. Janeway Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell 31:295-298, 1997.
37. Murphy, F. J., M. P. Hayes, and P. R. Burd. Disparate intracellular processing of human IL-12 preprotein subunits: atypical processing of the P35 signal peptide. J. Immunol. 164:839-847, 2000.
38. Naito, T., Y. Ozawa, M. Tomoyasu, M. Inagaki, M. Fukue, M. Sakai, T. Yamamoto, S. Ishikawa, and M. Onizuka. New method for evaluation of lung lymph flow rate with intact lymphatics in anaesthetized sheep. Act a Physiol. 188:139-149, 2006.
39. Ohno, R., Y. Yamaguchi, T. Toge, T. Kinouchi, T. Kotake, M. Shibata, Y. Kiyohara, S. Ikeda, I. Fukui, A. Gohchi, Y. Sugiyama, S. Saji, S. Hazama, M. Oka, K. Ohnishi, Y. Ohhashi, S. Tsukagoshi, and T. Taguchi. A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human Interleukin 12 and its biological effects in Japanese patients with advanced malignancies. Clin. Cancer Res. 6:2661-2669, 2000.
40. O'Neill, D. W., S. Adams, and N. Bhardwaj. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104:2235-2246, 2004.
41. Ottino, J. M. New tools, new outlooks, new opportunities. AIChE J. 51:1840-1845, 2005.
42. Park, G. Y., and J. W. Christman. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:797-805, 2006.
43. Presky, D. H., L. J. Minetti, S. Gillessen, V. L. Wilkinson, C. Y. Wu, U. Gubler, R. Chizzonite, and M. Gately. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. J. Immunol. 160:2174-2179, 1998.
44. Rich, I. N. Monocytes and Macrophages. In: Human Cell Culture, Vol. 4, Primary Hematopoietic Cells, edited by M. R. Koller and B. O. Palsson. Kluwer Academic Publishers, 1999, pp. 125-145.
45. Seder, R. A., and W. E. Paul. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol. 12:635-673, 1994.
46. Smith, K. A. The quantal theory of how the immune system discriminates between "self and non-self. Med. Immunol. 3:3, 2004.
47. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593-1598, 1998.
48. Sozzani, S. Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 16:581-592, 2005.
49. Suzuki, H., M. Takei, M. Yanagida, T. Nakahata, T. Kawakami, and H. Fukamachi. Early and late events in FcεeR1 signal transduction in human cultured mast cells. J. Immunol. 159:5881-5888, 1997.
50. Thompson, C. B. New insights into V(D)J recombination and its role in the evolution of the immune system. Immunity 3:531-539, 1995.
51. Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146, 2003.
52. Tsurui, H., H. Nishimura, S. Hattori, S. Hirose, K. Okumura, and T. Shirai. Seven-color fluorescence imaging of tissue samples based on Fourier spectroscopy and singular value decomposition. J. Histochem. Cytochem. 48:653-662, 2000.
53. Upham, J. W., J. Lundahl, H. Liang, J. A. Denburg, P. M. O'Byrne, and D. P. Snider. Simplified quantitation of myeloid dendritic cells in peripheral blood using flow cytometry. Cytometry 40:50-59, 2000.
54. Vermaelen, K. Y., I. Carro-Muino, B. N. Lambrecht, and R. A. Pauwels. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51-60, 2001.
55. Vermaelen, K. Y., and R. A. Pauwels. Pulmonary dendritic cells. Am. J. Respir. Crit. Care Med. 172:530-551, 2005.
56. Vlachos, D. G. A review of multiscale analysis: examples from systems biology, materials engineering, and other fluid-surface interacting systems. Adv. Chem. Eng. 30:1-61, 2005.
57. Whitelaw, D. M. The intravascular lifespan of monocytes. Blood 28:455-464, 1966.
58. Woodhead, V. E., M. H. Binks, B. M. Chain, and D. R. Katz. From sentinel to messenger: an extended phenotypic analysis of the monocyte to dendritic cell transition. Immunology 94:552-559, 1998.
59. Yates, A., C. C. Chan, R. E. Callard, A. J. George, and J. Stark. An approach to modelling in immunology. Brief Bioinform. 2:245-257, 2001.